Charité HT-Prostate

计划入组 100 人 · 首次发布于 2019 年 11 月 12 日

A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection

计划入组 86 人 · 首次发布于 2025 年 9 月 19 日

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

计划入组 17 人 · 首次发布于 2013 年 5 月 7 日

HT-020/HT-040

Transthyretin targeting siRNA therapeutic (Argo Biopharma)

HT-101

ARGO BIOPHARMA AUSTRALIA PTY LTD

Australia

LABORATOIRES URGO

France

ARJO AB

Alamar Biosciences Partners with SciLifeLab to Advance Precision Proteomics for Early Disease Detection

Alamar Biosciences Secures $50M+ Financing to Advance Precision Proteomics Platform for Early Disease Detection

Alzheimer's Drug Discovery Foundation Invests Record $10M in Alamar Biosciences for Blood-Based Diagnostic Platform